Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pluvicto availability waiting lists 2026?Glycopyrrolate other names?Does lipitor alter wine's aroma?Atrovent hfa discontinued boehringer ingelheim?Glycopyrrolate name brand?
See the DrugPatentWatch profile for Xalatan
What is the generic name for the eye pressure medication Xalatan? The generic name for Xalatan, a medication used to treat glaucoma, is latanoprost. This medication is a prostaglandin analog that works by decreasing the pressure inside the eye. Latanoprost is a widely prescribed treatment in the United States and other countries [1]. Who makes generic versions of latanoprost, and are they interchangeable with Xalatan? Several pharmaceutical companies manufacture generic versions of latanoprost, including Apotex, Teva, and Sun Pharma, among others. These generic medications have been shown to be bioequivalent to Xalatan, meaning they have similar absorption and bioavailability [2]. While generic medications are generally considered to be interchangeable with their brand-name counterparts, patients should always consult their doctor or pharmacist before switching to ensure a smooth transition. When did the patent for Xalatan expire, and what implications does this have for patients and prescribers? The patent for Xalatan expired in 2011, allowing generic versions of latanoprost to enter the market [3]. This has led to increased competition and potentially lower prices for patients. However, it is essential for patients and prescribers to be aware of any potential differences in formulation or packaging between generic and brand-name medications. Where can patients find more information about latanoprost, and what are their concerns? Patients interested in learning more about latanoprost can visit the manufacturer's website or consult with their doctor or pharmacist. Common concerns include the potential for eye irritation, changes in eye color, or interactions with other medications [4]. It is essential for patients to discuss these risks with their healthcare provider and report any concerns or side effects. Sources: [1] Generic and Brand Name Medications. (n.d.). In MedBroadcast. https://www.medbroadcast.com/drugs/getgeneric/name-brand [2] Bioequivalence Testing. (n.d.). In BioequivalenceTesting.com. https://www.bioequivalencetesting.com/ [3] Xalatan (Latanoprost). (n.p.). In DrugPatentWatch.com. https://www.drugpatentwatch.com/drug/xalatan-latanoprost/ [4] Latanoprost (Xalatan). (n.d.). In Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/latanoprost-xalatan/description/drg-20069412
Other Questions About Xalatan :